# Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian Patients

> **NCT04918017** · PHASE4 · UNKNOWN · sponsor: **University of Malaya** · enrollment: 180 (estimated)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Treatment based on subtypes: Esomeprazole or Itopride
- **DRUG:** Treatment with proton pump inhibitor regardless of subtype: Esomeprazole

## Key facts

- **NCT ID:** NCT04918017
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-18
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918017, "Treatment Outcomes For Functional Dyspepsia Based On Current International Guidelines In Multi-Ethnic Asian Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04918017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*